D. Bradshaw - Concepedia

Author

D. Bradshaw

Also Known As

Bradshaw, D., Bradshaw, David, D Bradshaw, D'Bria A. Bradshaw, D'Bria Bradshaw, D. BRADSHAW, D. Bradshaw, D. J. Bradshaw, D.J. Bradshaw, DAVID BRADSHAW

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Roche (United Kingdom)Florida Atlantic University Harbor Branch Oceanographic Institute Shepton Mallet Community Hospital Roche (Switzerland)

About

D. Bradshaw is an author at Roche (United Kingdom) specializing in medicine, inflammation, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	194
2	Engineering	2	2	39
3	Allergy	2	2	54
4	Natural Sciences	1	1	22
5	Biochemistry	1	1	22

D. Bradshaw

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Microbial Biofilm Formation and Contamination of Dental-Unit Water Systems in General Dental Practice James T. Walker, D. Bradshaw, Allan Bennett, Applied and Environmental Microbiology	2000	251
Microbial aerosols in general dental practice Allan Bennett, M. Fulford, John T. Walker, BDJ Microbial AerosolsOral HygieneOral MicrobiologyDental HygieneMicrobiology	2000	187
Microbiological Evaluation of a Range of Disinfectant Products To Control Mixed-Species Biofilm Contamination in a Laboratory Model of a Dental Unit Water System John T. Walker, D. Bradshaw, M. Fulford, Applied and Environmental Microbiology	2003	162
Ro 32‐3555, an orally active collagenase inhibitor, prevents cartilage breakdown <i>in vitro</i> and <i>in vivo</i> E. J. Lewis, Joshua D. Bishop, K M K Bottomley, British Journal of Pharmacology	1997	135
Ro 32-0432, a selective and orally active inhibitor of protein kinase C prevents T-cell activation. A M Birchall, J Bishop, D. Bradshaw, Journal of Pharmacology and Experimental Therapeutics	1994	90
(E)-2(R)-[1(S)-(Hydroxycarbamoyl)-4-phenyl-3-butenyl]-2′-isobutyl-2′-(methanesulfonyl)-4-methylvalerohydrazide (Ro 32-7315), a Selective and Orally Active Inhibitor of Tumor Necrosis Factor-α Convertase Gregory Beck, Gillian A. Bottomley, D. Bradshaw, Journal of Pharmacology and Experimental Therapeutics	2002	52
Oral anaerobes cannot survive oxygen stress without interacting with facuItative/aerobic species as a microbial commmunity D. Bradshaw, Philip Marsh, G.K. Watson, Letters in Applied Microbiology	1997	51
Inhibition of bovine nasal cartilage degradation by selective matrix metalloproteinase inhibitors K M K Bottomley, Neera Borkakoti, D. Bradshaw, Biochemical Journal Laboratory ImmunologyImmunologyGlycobiologyImmunotherapyMusculoskeletal Research	1997	44
Dynamics of microcystins and saxitoxin in the Indian River Lagoon, Florida Abdiel E. Laureano-Rosario, Malcolm McFarland, D. Bradshaw, Harmful Algae Aquatic EcologyWater QualityEcotoxicologyAquatic OrganismIndian River Lagoon	2021	31
Pharmacological and biochemical activities of Tenoxicam (Ro 12-0068), a new non-steroidal anti-inflammatory drug D. Bradshaw, C. H. Cashin, Arion Kennedy, Inflammation Research InflammationAnti-inflammatoryLipid PeroxidationPharmacologyPharmacological Agent	1984	30

Page 1